Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  MET tyrosine kinase inhibitor SAR125844
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: TED11449, NCI-2015-00488, 2010-021398-36, U1111-1117-9878, NCT01391533
Start Over